Status:
COMPLETED
A Comparative Trial of Standard 12 Lead ECG to the 12 Lead ECG Glove to Assess Cardiac Electrical Function
Lead Sponsor:
NYU Langone Health
Conditions:
Cardiac Electrical Function
Eligibility:
All Genders
18+ years
Brief Summary
The proposed study is a two-arm, randomized, single-blinded, cross-over Phase III clinical trial in which patients in 3 distinct clinical scenarios will receive the 12LEG, followed by the standard ECG...
Eligibility Criteria
Inclusion
- Preop assessment for elective cardiac catheterization or EP procedure.
- Outpatient cardiology appointments.
- Inpatients admitted with a cardiac diagnosis
Exclusion
- Age less than 18.
- Skin breakdown.
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01218334
Start Date
June 1 2008
End Date
February 1 2012
Last Update
November 9 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York University Medical Center
New York, New York, United States, 10016